Stock listing

NASDAQ:KURA Kura Oncology, Inc. Stock

Home listing (NASDAQ) of Kura Oncology, Inc.

Follow Kura Oncology, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:KURA

$9.08 USD -0.62 (-6.4%)

Close on Oct 16, 2026

Since Jul 6, 2026 -17.8% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
$9.05 – $9.68 USDOct 16, 2026
Volume
1.78M sharesOct 16, 2026
Market value
$807.8M USDAt the close on Oct 16, 2026 · price × 88.96M shares outstanding
Kura Oncology, Inc. logo
Ticker
NASDAQ:KURA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Kura Oncology (NASDAQ:KURA) Q2 2026 Earnings Call

    Wed, Aug 12, 2026 · 4:30 PM ET

    Watch Transcript

  • Kura Oncology (NASDAQ:KURA) Q1 2026 Earnings Call

    Tue, May 12, 2026 · 4:30 PM ET

    Watch Transcript

  • Kura Oncology (NASDAQ:KURA) Q4 2025 Earnings Call

    Thu, Mar 05, 2026 · 8:00 AM ET

    Watch Transcript

Latest news

Caspian Therapeutics and Kura Oncology Outline KO-7246 Development Strategy in Diabetes

Oct 13, 2026

Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes

Oct 7, 2026

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Oct 2, 2026

A Taste of Mystery: Kura Sushi USA and Crunchyroll Brew Up a New Collab with The Apothecary Diaries

Sep 17, 2026

Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes

Sep 9, 2026

Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer

Sep 8, 2026

Kura Oncology to Participate in Three Investor Conferences in September

Sep 1, 2026

Kura Oncology Reports Second Quarter 2026 Financial Results

Aug 12, 2026

Kura Oncology Announces Publication in Blood Highlighting Ziftomenib's Differentiated Binding Profile and Preclinical Activity

Aug 11, 2026

Kura Oncology to Report Second Quarter Financial Results

Aug 5, 2026

All Kura Oncology, Inc. news

Decks

Kura Oncology, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
40 in the last 12 months · 203 in all · newest Oct 13, 2026 · oldest 2019
Calls
23 calls with a replay · 23 with a transcript · latest Aug 12, 2026
Decks
53 decks · latest Aug 12, 2026

Where Kura Oncology, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:KURA · Home listing · This pageNASDAQUnited StatesUSD
gettex:KURgettexGermanyEUR
LS Exchange:A143UHLS ExchangeGermanyEUR
Lang & Schwarz:A143UHLang & SchwarzGermanyEUR
Frankfurt:KURFrankfurtGermanyEUR
BOATS:KURABOATSUnited StatesUSD
Tradegate:KURTradegateGermanyEUR
Hamburg:KURHamburgGermanyEUR
Stuttgart:KURStuttgartGermanyEUR
Dusseldorf:KURDusseldorfGermanyEUR

Log in to ask 6ix AI your own questions about Kura Oncology, Inc.